Nexosome Oncology Holdings
Lexington, US · Founded 2021 · Delaware corporation · 1 known investors
Founders & leadership
AE
Alan EzrinNamed on SEC filing
TH
Todd HembroughNamed on SEC filing
RS
Robert SaundersNamed on SEC filing
MD
Matthew DickenNamed on SEC filing
Board
BB
Investors · 1
Reported raises · per SEC filings
Form D private placements$3.7M disclosed across 1 round · 2021
▶$3.7MraisedNov 2021 · 48 investors · Other Health CareRule 506(b)
▶$3.7MraisedNov 2021 · 48 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alan EzrinDirector
- Todd HembroughExecutive Officer, Director
- Robert SaundersDirector
- Brian BrohmanDirector
- Matthew DickenDirector
- Offering amount
- $4M
- Amount sold
- $3.7M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nexosome Oncology Holdings's investors?
- Nexosome Oncology Holdings's investors include Rev1 Ventures.
- How much funding has Nexosome Oncology Holdings raised?
- Nexosome Oncology Holdings has disclosed $3.7M raised across 1 round.
- Where is Nexosome Oncology Holdings headquartered?
- Nexosome Oncology Holdings is headquartered in Lexington, US.